This is the first of a series of four papers that describe a 3-year EU-funded research project into the application of passive downdraught evaporative cooling to non-domestic buildings. In this paper various evaporative cooling techniques are reviewed. By spraying fine droplets of water at the top of atria, a downdraught of air cooled by evaporation can be produced. Such direct evaporative cooling using an evaporation tower appears to be a suitable approach for partly displacing the need for air-conditioning in hot, dry climates. It can satisfy fresh air requirements and reduce or eliminate demand for mechanical cooling. Examples of this cooling technique in Southern Europe and the Middle East have already demonstrated its operation and potential energy savings. However, limitations, primarily due to control of the system, have been identified. This introductory paper presents the theoretical basis of evaporative cooling, reviews some historical precedents, and discusses their relative strengths and weaknesses. Three further papers in this series will disseminate the main findings of the project.

Keywords:
Passive downdraught evaporative cooling, Energy, Ventilation
This content is only available via PDF.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.